Dina Kianoury
Critical Care Medicine · Washington, DCNPI 1891794053
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 71.5% of it on its own, with 7 other manufacturers making up the rest.
Across 46 payments — averaging $100.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Jazz Pharmaceuticals Inc.$367
- Intuitive Surgical$276
- Idorsia Pharmaceuticals US Inc$197
- AstraZeneca$123
- Amgen$123
- plus $235 from 2 others
What the payments were for
- Travel & lodging$1,79739%
- Food & beverage$2,73959%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 31 | $3,314 |
| Jazz Pharmaceuticals Inc. | 3 | $367 |
| Intuitive Surgical | 4 | $276 |
| Idorsia Pharmaceuticals US Inc | 2 | $197 |
| AstraZeneca | 1 | $123 |
| Amgen | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Harmony Biosciences LLC | 3 | $115 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,628
- XYWAV$268
- TEZSPIRE$246
- SUNOSI$120
- Inspire Upper Airway Stimulation System$119
- QUVIVIQ$118
- Da Vinci Surgical System$100
How this compares
$4,635 in reported general payments places this provider in the 85th percentile of 59 critical care medicine providers in District of Columbia.
See all critical care medicine providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 72 | $75,925 |
| XolairOmalizumab | 13 | $68,358 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 29 | $4,115 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,113 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $2,264 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,339 |
| Fluticasone Propionate | 39 | $489 |
| Gabapentin | 81 | $404 |
| Montelukast Sodium | 18 | $397 |
| Trazodone Hcl | 21 | $159 |
| Prednisone | 11 | $56 |
| Azithromycin | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Washington
- Lakhmir ChawlaWashington$441K
- Jonathan ChowWashington$285K
- Tunay KuruWashington$81K
- Vivek JainWashington$14K
- Kellen MulhernWashington$10K
- Jacob CollenWashington$8K
- Danielle DavisonWashington$5K
- Andrew HillWashington$5K
- Brian LeeWashington$3K
- Pramod BhattaraiWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.